BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31160356)

  • 1. A novel
    Lamb R; Rohrer JD; Real R; Lubbe SJ; Waite AJ; Blake DJ; Walters RJ; Lashley T; Revesz T; Holton JL; Morris HR
    Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort.
    Van Mossevelde S; van der Zee J; Gijselinck I; Engelborghs S; Sieben A; Van Langenhove T; De Bleecker J; Baets J; Vandenbulcke M; Van Laere K; Ceyssens S; Van den Broeck M; Peeters K; Mattheijssens M; Cras P; Vandenberghe R; De Jonghe P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C;
    Brain; 2016 Feb; 139(Pt 2):452-67. PubMed ID: 26674655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable clinical phenotype in TBK1 mutations: case report of a novel mutation causing primary progressive aphasia and review of the literature.
    Swift IJ; Bocchetta M; Benotmane H; Woollacott IO; Shafei R; Rohrer JD
    Neurobiol Aging; 2021 Mar; 99():100.e9-100.e15. PubMed ID: 32980182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts.
    Le Ber I; De Septenville A; Millecamps S; Camuzat A; Caroppo P; Couratier P; Blanc F; Lacomblez L; Sellal F; Fleury MC; Meininger V; Cazeneuve C; Clot F; Flabeau O; LeGuern E; Brice A;
    Neurobiol Aging; 2015 Nov; 36(11):3116.e5-3116.e8. PubMed ID: 26476236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel TBK1 variant associated with Frontotemporal Dementia overlap syndrome.
    Arshad F; Vengalil S; Nalini A; Polavarapu K; Shamim U; Jabeen S; Nagaraj C; Ramakrishnan S; Faruq M; Alladi S
    Acta Neurol Scand; 2022 Apr; 145(4):399-406. PubMed ID: 34841512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond ALS and FTD: the phenotypic spectrum of TBK1 mutations includes PSP-like and cerebellar phenotypes.
    Wilke C; Baets J; De Bleecker JL; Deconinck T; Biskup S; Hayer SN; Züchner S; Schüle R; De Jonghe P; Synofzik M
    Neurobiol Aging; 2018 Feb; 62():244.e9-244.e13. PubMed ID: 29137817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SQSTM1 variant in disorders of the frontotemporal dementia-amyotrophic lateral sclerosis spectrum: identification of a novel heterozygous variant and a review of the literature.
    Li W; Gao H; Dong X; Zheng D
    J Neurol; 2021 Apr; 268(4):1351-1357. PubMed ID: 33125541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
    Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
    Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the TBK1 mutation p.Ile334Thr with frontotemporal dementia and literature review.
    Yu H; Yu W; Luo SS; Yang YJ; Liu FT; Zhang Y; Chen Y; Sun YM; Wu JJ
    Mol Genet Genomic Med; 2019 Mar; 7(3):e547. PubMed ID: 30672142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between TBK1 mutations and risk of amyotrophic lateral sclerosis/frontotemporal dementia spectrum: a meta-analysis.
    Cui R; Tuo M; Li P; Zhou C
    Neurol Sci; 2018 May; 39(5):811-820. PubMed ID: 29349657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
    van der Zee J; Gijselinck I; Van Mossevelde S; Perrone F; Dillen L; Heeman B; Bäumer V; Engelborghs S; De Bleecker J; Baets J; Gelpi E; Rojas-García R; Clarimón J; Lleó A; Diehl-Schmid J; Alexopoulos P; Perneczky R; Synofzik M; Just J; Schöls L; Graff C; Thonberg H; Borroni B; Padovani A; Jordanova A; Sarafov S; Tournev I; de Mendonça A; Miltenberger-Miltényi G; Simões do Couto F; Ramirez A; Jessen F; Heneka MT; Gómez-Tortosa E; Danek A; Cras P; Vandenberghe R; De Jonghe P; De Deyn PP; Sleegers K; Cruts M; Van Broeckhoven C; Goeman J; Nuytten D; Smets K; Robberecht W; Damme PV; Bleecker J; Santens P; Dermaut B; Versijpt J; Michotte A; Ivanoiu A; Deryck O; Bergmans B; Delbeck J; Bruyland M; Willems C; Salmon E; Pastor P; Ortega-Cubero S; Benussi L; Ghidoni R; Binetti G; Hernández I; Boada M; Ruiz A; Sorbi S; Nacmias B; Bagnoli S; Sorbi S; Sanchez-Valle R; Llado A; Santana I; Rosário Almeida M; Frisoni GB; Maetzler W; Matej R; Fraidakis MJ; Kovacs GG; Fabrizi GM; Testi S
    Hum Mutat; 2017 Mar; 38(3):297-309. PubMed ID: 28008748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.
    Root J; Merino P; Nuckols A; Johnson M; Kukar T
    Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the
    Dols-Icardo O; García-Redondo A; Rojas-García R; Borrego-Hernández D; Illán-Gala I; Muñoz-Blanco JL; Rábano A; Cervera-Carles L; Juárez-Rufián A; Spataro N; De Luna N; Galán L; Cortes-Vicente E; Fortea J; Blesa R; Grau-Rivera O; Lleó A; Esteban-Pérez J; Gelpi E; Clarimón J
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):162-168. PubMed ID: 28889094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.
    Seltman RE; Matthews BR
    CNS Drugs; 2012 Oct; 26(10):841-70. PubMed ID: 22950490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical heterogeneity within the ALS-FTD spectrum in a family with a homozygous optineurin mutation.
    Parvizi T; Klotz S; Keritam O; Caliskan H; Imhof S; König T; Haider L; Traub-Weidinger T; Wagner M; Brunet T; Brugger M; Zimprich A; Rath J; Stögmann E; Gelpi E; Cetin H
    Ann Clin Transl Neurol; 2024 Jun; 11(6):1579-1589. PubMed ID: 38689506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.
    Shen T; Vogel JW; Duda J; Phillips JS; Cook PA; Gee J; Elman L; Quinn C; Amado DA; Baer M; Massimo L; Grossman M; Irwin DJ; McMillan CT
    Transl Neurodegener; 2023 Dec; 12(1):57. PubMed ID: 38062485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and structural consequences of TBK1 missense variants in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Gurfinkel Y; Polain N; Sonar K; Nice P; Mancera RL; Rea SL
    Neurobiol Dis; 2022 Nov; 174():105859. PubMed ID: 36113750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease.
    Pottier C; Bieniek KF; Finch N; van de Vorst M; Baker M; Perkersen R; Brown P; Ravenscroft T; van Blitterswijk M; Nicholson AM; DeTure M; Knopman DS; Josephs KA; Parisi JE; Petersen RC; Boylan KB; Boeve BF; Graff-Radford NR; Veltman JA; Gilissen C; Murray ME; Dickson DW; Rademakers R
    Acta Neuropathol; 2015 Jul; 130(1):77-92. PubMed ID: 25943890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel
    Seibert K; Smith H; Lapins A; Pytel P; Mastrianni JA
    Front Neurol; 2022; 13():826676. PubMed ID: 35309588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and clinical landscape of Chinese frontotemporal dementia: dominance of TBK1 and OPTN mutations.
    Nan H; Kim YJ; Chu M; Li D; Li J; Jiang D; Wu Y; Ohtsuka T; Wu L
    Alzheimers Res Ther; 2024 Jun; 16(1):127. PubMed ID: 38872230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.